The rational design of potential chemo therapeutic agents: Synthesis of bryostatin analogues

Medicinal Research Reviews

Volumn 19, Issue 5, 1999, Pages 388-407

  Wender, Paul A ^a   Hinkle, Kevin W ^a   Koebler, Michael F T ^a   Lippa, Blaise ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Analogue; Bryostatin; Computer; NMR; Synthesis

Indexed keywords

BRYOSTATIN; NATURAL PRODUCT; PROTEIN KINASE C;

BINDING AFFINITY; CANCER CHEMOTHERAPY; COMPUTER MODEL; CONFERENCE PAPER; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG STRUCTURE; GROWTH INHIBITION; MOLECULAR RECOGNITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOCHEMISTRY;

ADJUVANTS, IMMUNOLOGIC; ANTINEOPLASTIC AGENTS; COMPUTER SIMULATION; DRUG DESIGN; ENZYME ACTIVATION; HUMANS; ISOENZYMES; LACTONES; MACROLIDES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CHEMICAL; PROTEIN KINASE C;

EID: 0032859724     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1128(199909)19:5<388::AID-MED6>3.0.CO;2-H     Document Type: Conference Paper

References (80)

1. Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK. In: SEER cancer statistics review: 1973-1995. Bethesda, MD: National Cancer Institute; 1998.
2. Sikic BI. In: Craig CRS, RD, editor. Modern pharmacology. Boston: Little Brown & Co.; 1997. pp. 659-666.
3. Suffness M, Newman DJ, Snader K. In: Scheuer PJ, editor. Bioorganic marine chemistry 3. New York: Springer-Verlag Publishers, pp. 131-168.
4. Pettit GR, Herald CL, Doubek DL, Herald DL, Arnold E, Clardy J. J Am Chem Soc 1982;104:6846-6848.
5. Pettit GR. J Nat Prod 1996;59:812-821 and references cited therein.
6. Pettit GR. Fortschritte 1991;57:153 and references cited therein.
7. Kerr RG, Lawry J, Gush KA. Tett Lett 1996;37:8305-8308.
8. Information on the performance of Bryostatin 1 in various in vitro cell assays can be found at the NCI web site: http://epnws1.ncifcrf.gov:2345/dis3d/itb/stdagnt.html
9. Hornung RL, Pearson JW, Beckwith M, Longo DL. Cancer Res 1992;52:101-107.
10. Schuchter LM, Esa AH, May WS, Laulis MK, Pettit GR, Hess AD. Cancer Res 1991;51:682-687.
11. Mohammad RM, Varterasian ML, Almatchy VP, Hannoudi GN, Pettit GR, Alkatib A. Clin Cancer Res 1998;4:1337-1343.
12. Zhang XS, Zhang RW, Zhao H, Cai HY, Gush KA, Kerr RG, Pettit GR, Kraft AS. Cancer Res 1996;56:802-808.
13. Current information on bryostatin clinical trials can be found on the internet at: http://cancernet.nci.nih. gov/prot/protsrch.shtml
14. Stone RM, Galinsky I, Berg D, Daftary F, Kinchla N, Zaleskas JM, Xu G, Liou JR. Blood 1998;92(#10/ pt.1/S1):2602-2602.
15. Varterasian M, Mohammad R, Shurafa M, Eilender D, Murgo A, Hulburd K, Rodriguez D, Pemberton P, Lagrone F, Manica B, Spadoni V, Alkatib A. Blood 1998;92(#10/pt.1/S1):1702-1702.
16. Varterasian ML, Mohammad RM, Eilender DS, Hulburd K, Rodriguez DH, Pemberton PA, Pluda JM, Dan MD, Pettit GR, Chen BDM, Alkatib AM. J Clin Oncol 1998;16:56-62.
17. Propper DJ, Macaulay V, Obyrne KJ, Braybrooke JP, Wilner SM, Ganesan TS, Talbot DC, Harris AL. Br J Cancer 1998;78:1337-1341.
18. Grant S, Roberts J, Poplin E, Tombes MB, Kyle B, Welch D, Carr M, Bear HD. Clin Cancer Res 1998;4:611-618.
19. Varterasian M, Eilender D, Mohammad R, Chen B, Hulburd K, Rodriguez D, Pluda J, Valdivieso M, Alkatib A. Blood 1996;88(#10/pt.1/S1):2269-2269.
20. Jayson GC, Crowther D, Prendiville J, McGown AT, Scheid C, Stern P, Young R, Brenchley P, Chang J, Owens S, Pettit GR. Br J Cancer 1995;72:461-468.
21. Prendiville J, Crowther D, Thatcher N, Woll PJ, Fox BW, McGown A, Testa N, Stern P, McDermott R, Potter M, Pettit GR. Br J Cancer 1993;68:418-424.
22. Philip PA, Rea D, Thavasu P, Carmichael J, Stuart NSA, Rockett H, Talbot DC, Ganesan T, Pettit GR, Balkwill F, Harris AL. J Natl Cancer Inst 1993;85:1812-1818.
23. Hickman PF, Kemp GJ, Thompson CH, Salisbury AJ, Wade K, Harris AL, Radda GK. Br J Cancer 1995;72:998-1003.
24. Thompson CH, Macaulay VM, Obryne KJ, Kemp GJ, Wilner SM, Talbot DC, Harris AL, Radda GK. Br J Cancer 1996;73:1161-1165.
25. Scheid C, Prendiville J, Jayson G, Crowther D, Fox B, Pettit GR, Stern PL. Cancer Immunol Immunother 1994;39:223-230.
26. Kraft AS, Woodley S, Pettit GR, Gao F, Coll JC, Wagner F. Cancer Chemother Pharmacol 1996;37:271-278.
27. Szallasi Z, Du L, Levine R, Lewin NE, Nguyen PN, Williams MD, Pettit GR, Blumberg PM. Cancer Res 1996;56:2105-2111 and references cited therein.
28. Lind DS, Tuttle TM, Bethke KP, Frank JL, McCrady CW, Bear HD. Surgical Oncol-Oxford 1993;2:273-282.
29. Alkatib A, Mohammad RM, Dan M, Hussein ME, Akhtar A, Pettit GR, Sensenbrenner LL. Exp Hematol 1993;21:61-65.
30. Maki A, Diwakaran H, Redman B, Alasfar S, Pettit GR, Mohammad RM, Alkatib A. Anti-Cancer Drugs 1995;6:392-397.
31. Mohammad RM, Diwakaran H, Maki A, Emara MA, Pettit GR, Redman B, Alkatib A. Leukemia Res 1995;19:667-673.
32. Spitaler M, Utz I, Hilbe W, Hofmann J, Grunicke HH. Biochem Pharmacol 1998;56:861-869.
33. DeVries DJ, Herald CL, Pettit GR, Blumberg PM. Biochem Pharmacol 1988;37:4069-4073.
34. Kraft AS, Smith JB, Berkow RL. Proc Natl Acad Sci USA 1986;83:1334-1338.
35. Berkow RL, Kraft AS. Biochem Biophys Res Commun 1985;131:1109-1116.
36. Ramsdell J, Pettit GR, Jashjian AH. J Biol Chem 1986;261:7073-7080.
37. Nishizuka Y. Nature 1984;308:693-698.
38. Caponigro F, French RC, Kaye SB. Anti-Cancer Drugs 1997;8:26-33; and references cited therein.
39. Stone RM, Sariban E, Pettit GR, Kufe DW. Blood 1988;72:208-213.
40. Dell'Aquila ML, Nguyen HT, Herald CL, Pettit GR, Blumberg PM. Cancer Res 1987;47:6006-6009.
41. Sako T, Yuspa SH, Herald CL, Pettit GR, Blumberg PM. Cancer Res 1987;47:5445-5450.
42. Dell'Aquila ML, Herald CL, Kamano Y, Pettit GR, Blumberg PM. Cancer Res 1988;48:3702-3708.
43. Gschwendt M, Furstenberger G, Rose-John S, Rogers M, Kittstein W, Pettit GR, Herald CL, Marks F. Carcinogenesis 1988;9:555-562.
44. Houssa B, Van Blitterswijk WJ. J Biochem 1998;331:677-680.
45. Lester DS, Epand RM. Protein Kinase C: Current concepts and future perspectives. West Sussex, England: Ellis Horwood; 1992.
46. Burns DJ, Bell RM, editors. J Biol Chem 1991;266:18330-18338.
47. Szallasi Z, Smith CB, Pettit GR, Blumberg PM. J Biol Chem 1994;269:2118-2124.
48. Szallasi Z, Kosa K, Smith CB, Dlugosz AA, Williams EK, Yuspa SH, Blumberg PM. Mol Pharmacol 1995;47:258-265.
49. Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM. Mol Pharmacol 1994;46:840-850.
50. Lu Z, Hornia A, JiangYW, Zang Q, Ohno S, Foster DA. Mol Cell Biol 1997;17:3418-3428.
51. Fukumoto S, Nishizawa Y, Hosoi M, Koyama H, Yamakawa K, Ohno S, Morii H. J Biol Chem 1997;272:13816-13822.
52. Ghayur BT, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, Pandey P, Datta R, Huang YY, Kharbanda S, Allen H, Kamen R, Wong W, Kufe D. J Exp Med 1996;2399-2404.
53. Bogi K, Lorenzo PS, Szallasi Z, Acs P, Wagner GS, Blumberg PM. Cancer Res 1998;58:1423-1428.
54. Wender PA, Irie K, Miller BL. Proc Natl Acad Sci USA 1995;92:239-243.
55. Irie K, Oie K, Nakahara A, Yanai Y, Ohigashi H, Wender PA, Fukuda H, Konishi H, Kikkawa U. J Am Chem Soc 1998;120:9159-9167.
56. Rouhi AM. Chem Eng News 1995;73:42-44.
57. For a review covering bryostatin synthesis, including work from the groups of Evans, Hale, Roy, Vandewalle, Yamamura, and Masamune, see: Norcross RD, Paterson I. Chem Rev 1995;95:2041-2114.
58. Kageyama M, Tamura T, Nantz MH, Roberts JC, Somfai P, Whritenour DC, Masamune S. J Am Chem Soc 1990;112:7407-7408.
59. Evans DA, Carter PH, Carreira EM, Prunet JA, Charette AB, Lautens M. Angew Chem Int Ed 1998;37:2354-2359.
60. Pettit GR, Sengupta D, Blumberg PM, Lewin NE, Schmidt JM, Kraft AS. Anti-Cancer Drug Design 1992;7:101-113.
61. Wender PA, Cribbs CM, Koehler KF, Sharkey NA, Herald CL, Kamano Y, Pettit GR, Blumberg PM. Proc Natl Acad Sci USA 1988;85:7197-7201.
62. Wender PA, Koehler KF, Sharkey NA, Dell'Aquila ML, Blumberg PM. Proc Natl Acad Sci USA 1986;83:4214-4218.
63. Wender PA, De Brabander J, Harran PG, Jimenez JM, Koehler MFT, Lippa B, Park C-M, Siedenbiedel C, Pettit GR. Proc Natl Acad Sci USA 1998;95:6624-6629.
64. To our knowledge, there is only a single report of a related transformation: Li G, Still WC, J Am Chem Soc 1993;115:3804-3805.
65. Mohamadi F, Richards NGJ, Guida WC, Liskamp R, Lipton M, Caufield C, Chang G, Hendrickson T, Still WC. J Comput Chem 1990;11:440-467.
66. Still WC, Tempczyk A, Hawley RC, Hendrickson T. J Am Chem Soc 1990;112:6127-6129.
67. Kamano YZ, Zhang HP, Morita H, Itokawa H, Shirota O, Pettit GR, Herald DL, Herald CL, Tetrahedron 1996;52:2369-2376.
68. Wender PA, De Brabander J, Harran PG, Jimenez JM, Koehler MFT, Lippa B, Park C-M, Shiozaki M, Pettit GR. J Am Chem Soc 1998;120:4534-4535.
69. Luche JL, Rodriguez-Hahn L, Crabbe P. J Chem Soc Chem Comm 1978;601-602.
70. Dess DB, Martin JC. J Am Chem Soc 1991;113:7277-7287.
71. Ireland RE, Liu L. J Org Chem 1993;58:2899.
72. Kelly TR, Schmidt TE, Haggerty JG. Synthesis 1972;544-545.
73. Inanaga J, Hirata K, Saeki H, Katsuki T, Yamaguchi M. Bull Chem Soc Jpn 1979;52:1989-1993.
74. Hikota M, Tone H, Horita K, Yonemitsu O. J Org Chem 1990;55:7-9.
75. HaradaT, Shintani T, Oku A. J Am Chem Soc 1995;117:12346-12347.
76. Danishefsky S, Kitahara T. J Am Chem Soc 1974;96:7807-7808.
77. Brown HC, Jadhav PK. J Am Chem Soc 1983;105:2092-2093.
78. Wender PA, De Brabander J, Harran PG, Hinkle KW, Lippa B, Pettit GR. Tett Lett 1998;39:8625-8628.
79. Mochly-Rosen D, Koshland Jr, DE. J Biol Chem 1986;262:2291-2297.
80. Tanaka Y, Miyake R, Kikkawa U, Nishizuka, Y. J Biochem 1987;99:257-261.